Effect of mild-to-moderate COVID‑19 on the incidence and risk factors for deep vein thrombosis in patients with hip

Haoran Li1, Jian Xing1, Zhe Song1

  • 1Orthopedic Trauma Department, Honghui Hospital, Xi'an Jiaotong University, Xi'an, China.

BMC Surgery
|March 25, 2025
PubMed

Insights

Mild-to-moderate COVID-19 did not significantly increase deep vein thrombosis (DVT) risk in hip fracture patients. Routine DVT prevention is recommended for all hip fracture patients, irrespective of SARS-CoV-2 infection status.

Area of Science:

  • Orthopedic Surgery
  • Infectious Diseases
  • Vascular Medicine

Background:

  • Hip fractures are prevalent in the elderly, with a significant proportion occurring in inpatients during the COVID-19 pandemic.
  • COVID-19's impact on deep vein thrombosis (DVT) risk is complex, with higher incidence reported in severe cases.
  • The specific risk of DVT associated with mild-to-moderate COVID-19 in hip fracture patients remains unclear.

Purpose of the Study:

  • To investigate the association between mild-to-moderate COVID-19 and the risk of deep vein thrombosis (DVT) in patients undergoing hip fracture surgery.
  • To identify independent risk factors for preoperative DVT in hip fracture patients.

Main Methods:

  • Retrospective analysis of adult patients who underwent hip fracture surgery between December 2022 and January 2023.
  • Preoperative screening for SARS-CoV-2 infection and Doppler ultrasonography (DUS) for DVT detection.
  • Logistic regression analysis to determine risk factors for DVT.

Main Results:

  • Out of 98 hip fracture patients, 63 tested positive for SARS-CoV-2. Overall DVT incidence was 37% (40% in COVID-19 positive, 31% in COVID-19 negative).
  • Mild-to-moderate COVID-19 was not found to be an independent risk factor for DVT in this cohort.
  • Preoperative leukocyte count and platelet-to-lymphocyte ratio (PLR) were identified as independent risk factors for DVT.

Conclusions:

  • COVID-19 infection, in its mild-to-moderate form, did not significantly elevate the risk of deep vein thrombosis in patients with hip fractures.
  • Standard deep vein thrombosis (DVT) prevention protocols should be consistently applied to all hip fracture patients, regardless of their COVID-19 status.
Abstract

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
583
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
212
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
10.7K